Jinneng Science & Technology Co Capital Expenditures
The Capital Expenditures (CapEx) of Jinneng Science & Technology Co (603113.SS) as of Aug 23, 2026 is -486.80 M CNY. In the previous year, Capital Expenditures (CapEx) was -2.22 B CNY — a change of -78.04% (higher).
Get this data via API
Financial Data API
Capital Expenditures
-486.80 MCNY
YoY
-78.04%
Last updated:
The Jinneng Science & Technology Co Capital Expenditures history
3 Years
10 Years
25 Years
Max
| YEAR | Capital Expenditures | YoY |
|---|---|---|
| -486.80 MCNY | -78.04% | |
| -2.22 BCNY | +26.62% | |
| -1.75 BCNY | +21.82% | |
| -1.44 BCNY | -40.06% | |
| -2.40 BCNY | +75.81% | |
| -1.36 BCNY | +76.84% | |
| -771.20 MCNY | +52.56% | |
| -505.50 MCNY | +438.91% | |
| -93.80 MCNY | -55.33% | |
| -210.00 MCNY | +149.70% | |
| -84.10 MCNY | — |
Jinneng Science & Technology Co Stock analysis
Frequently Asked Questions about Jinneng Science & Technology Co stock
Capital Expenditures (CapEx) of Jinneng Science & Technology Co is -486.80 M CNY in 2026.
Capital Expenditures (CapEx) of Jinneng Science & Technology Co changed from -2.22 B CNY to -486.80 M CNY, representing a -78.04% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Jinneng Science & Technology Co since 2006 – with annual values, charts, and detailed analysis.
Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.
Capital Expenditures (CapEx)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Jinneng Science & Technology Co historically and in real time.
Cash Flow — Jinneng Science & Technology Co
All Key Metrics — Jinneng Science & Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth